Oireachtas Joint and Select Committees
Wednesday, 21 November 2018
Joint Oireachtas Committee on Health
Evaluating Orphan Drugs: Discussion (Resumed)
9:00 am
Rose Conway Walsh (Sinn Fein) | Oireachtas source
That is the point. Is the EMA worth anything? Is it of any value at all or are its standards lower than the ones we have here? These treatments are often for children. Does a child in another country differ from one here? Why do we not take the EMA's decisions and say "Now we are here, what is the other part we need to get in order to get it approved in our country?" I cannot understand why we keep-----
No comments